WO2002085419A3 - Bifunctional-modified hydrogels - Google Patents
Bifunctional-modified hydrogels Download PDFInfo
- Publication number
- WO2002085419A3 WO2002085419A3 PCT/US2002/012621 US0212621W WO02085419A3 WO 2002085419 A3 WO2002085419 A3 WO 2002085419A3 US 0212621 W US0212621 W US 0212621W WO 02085419 A3 WO02085419 A3 WO 02085419A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hydrogels
- modified
- bifunctional
- entrained
- polymer matrix
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L101/00—Compositions of unspecified macromolecular compounds
- C08L101/12—Compositions of unspecified macromolecular compounds characterised by physical features, e.g. anisotropy, viscosity or electrical conductivity
- C08L101/14—Compositions of unspecified macromolecular compounds characterised by physical features, e.g. anisotropy, viscosity or electrical conductivity the macromolecular compounds being water soluble or water swellable, e.g. aqueous gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6903—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being semi-solid, e.g. an ointment, a gel, a hydrogel or a solidifying gel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/225—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
- A61L15/325—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
- Y10S530/815—Carrier is a synthetic polymer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
- Y10S530/815—Carrier is a synthetic polymer
- Y10S530/817—Entrapped within the carrier, e.g. gel, hollow fibre
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002582992A JP4340067B2 (en) | 2001-04-23 | 2002-04-23 | Bifunctional modified hydrogel |
EP02728891A EP1423093A4 (en) | 2001-04-23 | 2002-04-23 | Bifunctional-modified hydrogels |
CA002444880A CA2444880C (en) | 2001-04-23 | 2002-04-23 | Bifunctional-modified hydrogels |
AU2002258913A AU2002258913A1 (en) | 2001-04-23 | 2002-04-23 | Bifunctional-modified hydrogels |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28578201P | 2001-04-23 | 2001-04-23 | |
US60/285,782 | 2001-04-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002085419A2 WO2002085419A2 (en) | 2002-10-31 |
WO2002085419A3 true WO2002085419A3 (en) | 2004-03-18 |
Family
ID=23095662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/012621 WO2002085419A2 (en) | 2001-04-23 | 2002-04-23 | Bifunctional-modified hydrogels |
Country Status (6)
Country | Link |
---|---|
US (3) | US7615593B2 (en) |
EP (1) | EP1423093A4 (en) |
JP (1) | JP4340067B2 (en) |
AU (1) | AU2002258913A1 (en) |
CA (1) | CA2444880C (en) |
WO (1) | WO2002085419A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9095558B2 (en) | 2010-10-08 | 2015-08-04 | Board Of Regents, The University Of Texas System | Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications |
US9561309B2 (en) | 2004-05-27 | 2017-02-07 | Advanced Cardiovascular Systems, Inc. | Antifouling heparin coatings |
Families Citing this family (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6969367B2 (en) * | 2000-02-02 | 2005-11-29 | Xepmed, Inc. | Extracorporeal pathogen reduction system |
CA2444880C (en) * | 2001-04-23 | 2009-11-24 | Wisconsin Alumni Research Foundation | Bifunctional-modified hydrogels |
US20050276858A1 (en) * | 2001-04-23 | 2005-12-15 | Kao Weiyuan J | Bifunctional-modified hydrogels |
US7125558B2 (en) * | 2001-08-22 | 2006-10-24 | Bioartificial Gel Technologies Inc, | Process for the preparation of activated polyethylene glycols |
US7605231B2 (en) * | 2002-04-26 | 2009-10-20 | Yasuhiko Tabata | Gelatin derivatives and high-molecular micelle comprising the derivatives |
DK1656410T3 (en) | 2003-07-22 | 2010-06-28 | Nektar Therapeutics | Process for the preparation of functionalized polymers from polymer alcohols |
US7815561B2 (en) | 2003-09-25 | 2010-10-19 | Xoft, Inc. | Brachytherapy applicator |
WO2005037336A1 (en) * | 2003-10-21 | 2005-04-28 | Bioartificial Gel Technologies Inc. | Hydrogel-containing medical articles and methods of using and making the same |
ATE515245T1 (en) | 2003-12-11 | 2011-07-15 | Isto Technologies Inc | PARTICLE CARTILAGE SYSTEM |
US7351787B2 (en) * | 2004-03-05 | 2008-04-01 | Bioartificial Gel Technologies, Inc. | Process for the preparation of activated polyethylene glycols |
WO2005115489A2 (en) * | 2004-05-24 | 2005-12-08 | Genzyme Corporation | Adherent polymeric compositions |
JP4709956B2 (en) * | 2004-06-18 | 2011-06-29 | 国立大学法人北海道大学 | Artificial meniscus |
US8329958B2 (en) * | 2004-07-02 | 2012-12-11 | Biocon Limited | Combinatorial synthesis of PEG oligomer libraries |
US7968085B2 (en) | 2004-07-05 | 2011-06-28 | Ascendis Pharma A/S | Hydrogel formulations |
US20070207209A1 (en) * | 2004-08-27 | 2007-09-06 | Murphy Christopher J | Trophic factor combinations for nervous system treatment |
US20060074182A1 (en) * | 2004-09-30 | 2006-04-06 | Depuy Products, Inc. | Hydrogel composition and methods for making the same |
US20090088846A1 (en) * | 2007-04-17 | 2009-04-02 | David Myung | Hydrogel arthroplasty device |
US8821583B2 (en) | 2004-10-05 | 2014-09-02 | The Board Of Trustees Of The Leland Stanford Junior University | Interpenetrating polymer network hydrogel |
US8609131B2 (en) * | 2005-01-25 | 2013-12-17 | 3M Innovative Properties Company | Absorbent dressing comprising hydrophilic polymer prepared via Michael reaction |
WO2006085653A1 (en) * | 2005-02-14 | 2006-08-17 | Medgel Corporation | Hydrogel for medical use |
US20080206894A1 (en) * | 2005-05-24 | 2008-08-28 | Georgia Tech Research Corporation | Bioresponsive Hydrogels |
US20070014845A1 (en) * | 2005-07-01 | 2007-01-18 | Yuanpeng Zhang | Liposomal delivery vehicle for hydrophobic drugs |
US8998881B2 (en) | 2005-08-10 | 2015-04-07 | Alza Corporation | Method for delivering drugs to tissue under microjet propulsion |
GB0516846D0 (en) * | 2005-08-17 | 2005-09-21 | Knight David P | Meniscal repair device |
EP1916964A4 (en) | 2005-08-26 | 2015-11-04 | Zimmer Inc | Implants and methods for repair, replacement and treatment of joint disease |
CA2619709C (en) * | 2005-08-26 | 2012-05-01 | Novo Nordisk A/S | A method of modifying a macromolecular system |
EP1764117A1 (en) * | 2005-09-20 | 2007-03-21 | Zimmer GmbH | Implant for the repair of a cartilage defect and method for manufacturing the implant |
US20110166247A1 (en) * | 2006-12-07 | 2011-07-07 | David Myung | Interpenetrating polymer network hydrogel contact lenses |
ITRM20060682A1 (en) * | 2006-12-19 | 2008-06-20 | Sicit Chemitech S P A | NEW BIODEGRADABLE POLYMER DERIVATIVES |
US8163549B2 (en) | 2006-12-20 | 2012-04-24 | Zimmer Orthobiologics, Inc. | Method of obtaining viable small tissue particles and use for tissue repair |
CN101220090B (en) * | 2007-01-09 | 2010-10-13 | 上海百瑞吉生物医药有限公司 | Multi-modification derivant of glutin and crosslinked material thereof |
US8334044B2 (en) * | 2007-02-06 | 2012-12-18 | The Board Of Trustees Of The Leland Stanford Junior University | Hydrogel-metal assembly |
WO2008100617A1 (en) * | 2007-02-16 | 2008-08-21 | The Board Of Trustees Of The Leland Stanford Junior University | Strain-hardened interpenetrating polymer network hydrogel |
CA2684040C (en) | 2007-04-12 | 2016-12-06 | Isto Technologies, Inc. | Method of forming an implant using a mold that mimics the shape of the tissue defect site and implant formed therefrom |
US20080287633A1 (en) * | 2007-05-18 | 2008-11-20 | Drumheller Paul D | Hydrogel Materials |
ITMI20071236A1 (en) * | 2007-06-20 | 2008-12-21 | Sicit Chemitech Spa | PRODUCTION OF LEATHER AND FABRIC FROM MATERIALS CONTAINING HYDROLYSED PROTEINS AND GELATINS |
EP2240536B1 (en) | 2008-01-30 | 2019-09-04 | Asterias Biotherapeutics, Inc. | Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells |
JP5501981B2 (en) * | 2008-01-30 | 2014-05-28 | ジェロン・コーポレーション | Synthetic surface for culturing cells in a known composition medium |
KR101809863B1 (en) | 2008-01-30 | 2017-12-15 | 아스테리아스 바이오세라퓨틱스, 인크. | Synthetic surfaces for culturing stem cell derived cardiomyocytes |
WO2009099539A2 (en) * | 2008-01-30 | 2009-08-13 | Corning Incorporated | (meth)acrylate surfaces for cell culture, methods of making and using the surfaces |
US8329469B2 (en) * | 2008-01-30 | 2012-12-11 | Geron Corporation | Swellable (meth)acrylate surfaces for culturing cells in chemically defined media |
US20100280147A1 (en) * | 2008-02-15 | 2010-11-04 | Laura Hartmann | High refractive index interpenetrating networks for ophthalmic applications |
US8668863B2 (en) | 2008-02-26 | 2014-03-11 | Board Of Regents, The University Of Texas System | Dendritic macroporous hydrogels prepared by crystal templating |
US20090220578A1 (en) * | 2008-02-28 | 2009-09-03 | Depuy Products, Inc. | Hydrogel composition and method for making the same |
JP2011515162A (en) * | 2008-03-21 | 2011-05-19 | バイオミメディカ インコーポレイテッド | Methods, devices and compositions for adhering hydrated polymer implants to bone |
US20090280182A1 (en) * | 2008-04-30 | 2009-11-12 | Stayce Beck | Devices for the treatment of wounds and methods and kits therefor |
KR100967833B1 (en) * | 2008-05-20 | 2010-07-05 | 아이디비켐(주) | A method for preparing high-purity polyethyleneglycol aldehyde derivatives |
US20120209396A1 (en) | 2008-07-07 | 2012-08-16 | David Myung | Orthopedic implants having gradient polymer alloys |
US8883915B2 (en) | 2008-07-07 | 2014-11-11 | Biomimedica, Inc. | Hydrophobic and hydrophilic interpenetrating polymer networks derived from hydrophobic polymers and methods of preparing the same |
US20100010114A1 (en) * | 2008-07-07 | 2010-01-14 | David Myung | Hydrophilic Interpenetrating Polymer Networks Derived From Hydrophobic Polymers |
WO2010017282A1 (en) | 2008-08-05 | 2010-02-11 | Biomimedica, Inc. | Polyurethane-grafted hydrogels |
WO2010036800A1 (en) * | 2008-09-24 | 2010-04-01 | President And Fellows Of Harvard College | Porous electroactive hydrogels and uses thereof |
US20130146788A1 (en) * | 2009-04-14 | 2013-06-13 | The Regents Of The University Of California | Method of creating colored materials by fixing ordered structures of magnetite nanoparticles within a solid media |
US8362144B2 (en) * | 2009-05-21 | 2013-01-29 | Corning Incorporated | Monomers for making polymeric cell culture surface |
EP2459703A1 (en) | 2009-07-29 | 2012-06-06 | Corning Inc. | Functionalized cell binding peptides and cell culture articles |
US20110183418A1 (en) * | 2009-07-29 | 2011-07-28 | Arthur Winston Martin | Peptide-Polymer Cell Culture Articles and Methods of Making |
SG178193A1 (en) | 2009-07-31 | 2012-03-29 | Sanofi Aventis Deutschland | Prodrugs comprising an insulin linker conjugate |
KR101759499B1 (en) | 2009-07-31 | 2017-07-19 | 사노피-아벤티스 도이칠란트 게엠베하 | Long acting insulin composition |
NZ599527A (en) | 2009-11-09 | 2014-04-30 | Spotlight Technology Partners Llc | Fragmented hydrogels |
WO2011057131A1 (en) | 2009-11-09 | 2011-05-12 | Spotlight Technology Partners Llc | Polysaccharide based hydrogels |
WO2011123760A2 (en) | 2010-04-01 | 2011-10-06 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Whey protein isolate hydrogels and their uses |
KR101734853B1 (en) | 2010-06-08 | 2017-05-12 | 다우 글로벌 테크놀로지스 엘엘씨 | Method for the preparation of a particulate reversibly crosslinked polymeric material |
US20120003192A1 (en) * | 2010-07-02 | 2012-01-05 | Zimmer Orthobiologics, Inc. | Hydrogel-forming composition comprising protein and non-protein segments |
EP2438930A1 (en) | 2010-09-17 | 2012-04-11 | Sanofi-Aventis Deutschland GmbH | Prodrugs comprising an exendin linker conjugate |
WO2012048283A1 (en) | 2010-10-08 | 2012-04-12 | Board Of Regents, The University Of Texas System | One-step processing of hydrogels for mechanically robust and chemically desired features |
US10092660B2 (en) * | 2011-04-25 | 2018-10-09 | Stc.Unm | Solid compositions for pharmaceutical use |
US20130103157A1 (en) | 2011-10-03 | 2013-04-25 | Lampros Kourtis | Polymeric adhesive for anchoring compliant materials to another surface |
CA2856512A1 (en) | 2011-11-21 | 2013-05-30 | Biomimedica, Inc. | Systems, devices, and methods for anchoring orthopaedic implants to bone |
KR101269423B1 (en) * | 2011-12-22 | 2013-05-30 | 오스템임플란트 주식회사 | Hydrogel with controllable biodegradation behavior and the manufacturing method thereof |
US20140178343A1 (en) | 2012-12-21 | 2014-06-26 | Jian Q. Yao | Supports and methods for promoting integration of cartilage tissue explants |
WO2016204258A1 (en) * | 2015-06-19 | 2016-12-22 | 日産化学工業株式会社 | Polymer for gel formation and dermatological adhesive material |
US11077228B2 (en) | 2015-08-10 | 2021-08-03 | Hyalex Orthopaedics, Inc. | Interpenetrating polymer networks |
EP3521371B1 (en) * | 2016-10-03 | 2021-06-16 | DIC Corporation | Method for producing semi-ipn composite |
IT201600108137A1 (en) | 2016-10-26 | 2018-04-26 | Sicit Chemitech S P A | BIODEGRADABLE POLYMER DERIVATIVES |
CZ308284B6 (en) * | 2018-03-15 | 2020-04-15 | Ústav makromolekulární chemie AV ČR, v. v. i. | Preparation based on interpenetrating polymer networks for healing wounds |
US10869950B2 (en) | 2018-07-17 | 2020-12-22 | Hyalex Orthopaedics, Inc. | Ionic polymer compositions |
CN109078391A (en) * | 2018-08-03 | 2018-12-25 | 闽江学院 | A kind of hydrogel fills the composite filter element of porous filter material preparation |
CN109481730B (en) * | 2018-11-27 | 2021-10-26 | 五邑大学 | Calcium alginate/polyethylene glycol (glycol) diacrylate three-dimensional fiber network gel and preparation method and application thereof |
CA3133172A1 (en) * | 2019-03-13 | 2020-09-17 | Susmita Bose | Enzyme-degradable hydrogel for delivery of a payload |
CN113398321B (en) * | 2020-03-17 | 2022-04-12 | 天津大学 | Porous hemostatic sponge with high liquid absorption rate and high resilience, and preparation method and application thereof |
CN112007210A (en) * | 2020-08-24 | 2020-12-01 | 上海颐盏生物科技有限公司 | Photoinitiated polyethylene glycol-based hydrogel dressing and preparation method thereof |
CN112870432B (en) * | 2021-01-14 | 2021-12-10 | 东华大学 | Photo-repairable nanofiber hydrogel dressing and preparation method thereof |
WO2023205490A1 (en) * | 2022-04-22 | 2023-10-26 | The University Of Vermont And State Agricultural College | Polymer/milk-protein hydrogels, cell scaffolds and cultured meat products made therewith, and associated methods |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5153265A (en) * | 1988-01-20 | 1992-10-06 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
US6132765A (en) * | 1996-04-12 | 2000-10-17 | Uroteq Inc. | Drug delivery via therapeutic hydrogels |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4390519A (en) * | 1978-05-19 | 1983-06-28 | Sawyer Philip Nicholas | Bandage with hemostatic agent and methods for preparing and employing the same |
WO1990004611A1 (en) * | 1988-10-26 | 1990-05-03 | Anatoly Yakovlevich Sorokin | Copolymers of vinyl alcohol with vinyl acetate, cross-linked by glutaric dialdehyde, method of obtaining them and a pharmaceutical preparation based thereon |
US5936035A (en) * | 1988-11-21 | 1999-08-10 | Cohesion Technologies, Inc. | Biocompatible adhesive compositions |
US5162430A (en) * | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
EP0548344B1 (en) | 1991-07-09 | 1998-04-08 | Vitaphore Corporation | Collagen composites for controlled drug release |
IT1260154B (en) * | 1992-07-03 | 1996-03-28 | Lanfranco Callegaro | HYALURONIC ACID AND ITS DERIVATIVES IN INTERPENETRATING POLYMERS (IPN) |
JP3536186B2 (en) * | 1995-02-27 | 2004-06-07 | 独立行政法人 科学技術振興機構 | Biodegradable polymer hydrogel |
DE29624309U1 (en) | 1995-04-04 | 2002-01-03 | Novartis Ag | Duration supporting lenses |
US5847089A (en) * | 1995-06-07 | 1998-12-08 | Wisconsin Alumni Research Foundation | Carboxyl-modified superabsorbent protein hydrogel |
US6129761A (en) | 1995-06-07 | 2000-10-10 | Reprogenesis, Inc. | Injectable hydrogel compositions |
US5672662A (en) | 1995-07-07 | 1997-09-30 | Shearwater Polymers, Inc. | Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications |
US5863984A (en) * | 1995-12-01 | 1999-01-26 | Universite Laval, Cite Universitaire | Biostable porous material comprising composite biopolymers |
WO1997022371A1 (en) * | 1995-12-18 | 1997-06-26 | Collagen Corporation | Crosslinked polymer compositions and methods for their use |
JPH1085318A (en) * | 1996-09-18 | 1998-04-07 | Terumo Corp | Medical material and skin ulcer filling/recovering material |
US6258351B1 (en) | 1996-11-06 | 2001-07-10 | Shearwater Corporation | Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels |
WO1998028364A1 (en) | 1996-12-20 | 1998-07-02 | The Chinese University Of Hong Kong | Novel polymer gel composition and uses therefor |
US5904927A (en) * | 1997-03-14 | 1999-05-18 | Northeastern University | Drug delivery using pH-sensitive semi-interpenetrating network hydrogels |
US5906997A (en) * | 1997-06-17 | 1999-05-25 | Fzio Med, Inc. | Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions |
US6818018B1 (en) * | 1998-08-14 | 2004-11-16 | Incept Llc | In situ polymerizable hydrogels |
US6521431B1 (en) * | 1999-06-22 | 2003-02-18 | Access Pharmaceuticals, Inc. | Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments |
AU7004900A (en) * | 1999-07-21 | 2001-02-05 | Imedex Biomateriaux | Adhesive protein foam for surgical and/or therapeutic uses |
CA2345779A1 (en) * | 1999-08-27 | 2001-03-08 | Department Of National Defence | Hydrogel wound dressing containing liposome-encapsulated therapeutic agent |
US6348558B1 (en) * | 1999-12-10 | 2002-02-19 | Shearwater Corporation | Hydrolytically degradable polymers and hydrogels made therefrom |
US6310105B1 (en) * | 2000-02-15 | 2001-10-30 | Wisconsin Alumni Research Foundation | Carboxyl-modified superabsorbent protein hydrogel |
KR20030031480A (en) * | 2000-04-28 | 2003-04-21 | 프지오메드, 인코포레이티드 | Hemostatic compositions of polyacids and polyalkylene oxides and methods for their use |
US20050276858A1 (en) * | 2001-04-23 | 2005-12-15 | Kao Weiyuan J | Bifunctional-modified hydrogels |
CA2444880C (en) * | 2001-04-23 | 2009-11-24 | Wisconsin Alumni Research Foundation | Bifunctional-modified hydrogels |
-
2002
- 2002-04-23 CA CA002444880A patent/CA2444880C/en not_active Expired - Fee Related
- 2002-04-23 US US10/128,198 patent/US7615593B2/en not_active Expired - Fee Related
- 2002-04-23 WO PCT/US2002/012621 patent/WO2002085419A2/en active Application Filing
- 2002-04-23 JP JP2002582992A patent/JP4340067B2/en not_active Expired - Fee Related
- 2002-04-23 AU AU2002258913A patent/AU2002258913A1/en not_active Abandoned
- 2002-04-23 EP EP02728891A patent/EP1423093A4/en not_active Withdrawn
-
2005
- 2005-11-14 US US11/273,393 patent/US20060100369A1/en not_active Abandoned
-
2009
- 2009-11-10 US US12/615,859 patent/US8025901B2/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5153265A (en) * | 1988-01-20 | 1992-10-06 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
US6132765A (en) * | 1996-04-12 | 2000-10-17 | Uroteq Inc. | Drug delivery via therapeutic hydrogels |
Non-Patent Citations (1)
Title |
---|
See also references of EP1423093A4 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9561309B2 (en) | 2004-05-27 | 2017-02-07 | Advanced Cardiovascular Systems, Inc. | Antifouling heparin coatings |
US9095558B2 (en) | 2010-10-08 | 2015-08-04 | Board Of Regents, The University Of Texas System | Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications |
Also Published As
Publication number | Publication date |
---|---|
US8025901B2 (en) | 2011-09-27 |
WO2002085419A2 (en) | 2002-10-31 |
US20030083389A1 (en) | 2003-05-01 |
EP1423093A2 (en) | 2004-06-02 |
EP1423093A4 (en) | 2005-11-30 |
AU2002258913A1 (en) | 2002-11-05 |
US7615593B2 (en) | 2009-11-10 |
US20060100369A1 (en) | 2006-05-11 |
CA2444880A1 (en) | 2002-10-31 |
JP2004534111A (en) | 2004-11-11 |
US20100209509A1 (en) | 2010-08-19 |
CA2444880C (en) | 2009-11-24 |
JP4340067B2 (en) | 2009-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002085419A3 (en) | Bifunctional-modified hydrogels | |
PT1028753E (en) | LIBERATION OF POLY (ETHYLENE GLYCOL) MOLECULES - CONJUGATED FROM DEGRADABLE HYDROGELS | |
WO2002039948A3 (en) | Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants | |
DK0910412T3 (en) | Controlled release hydrolyzable hydrogels | |
CA2266581A1 (en) | Polymers containing polysaccharides such as alginates or modified alginates | |
WO2003084430A3 (en) | Superabsorbent polymers providing long-term generation of free volume in partially hydrated absorbent cores | |
CA2290743A1 (en) | Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering | |
WO2001000246A3 (en) | Hydrogels derived from chitosan and poly(ethylene glycol) | |
ATE356638T1 (en) | HYDROLYTICALLY DEGRADABLE CARBAMAT DERIVATIVES OF POLYETHYLENE GLYCOL | |
WO2002087001A3 (en) | Polymer electrolyte membrane | |
AU6192299A (en) | Functionalized derivatives of hyaluronic acid and formation of hydrogels in situusing same | |
ATE255422T1 (en) | DEGRADABLE, HETEROBIFUNCTIONAL POLYETHYLENE GLYCOL ACRYLATES, AND GEL AND CONJUGATES THAT CAN BE PRODUCED THEM | |
AU2383500A (en) | Hydrophilic ampholytic polymer | |
AU1507595A (en) | Collagen-synthetic polymer matrices prepared using multiple step reaction | |
AU6921700A (en) | Solid polymer electrolytes | |
BR0211402A (en) | Irreversibly Immobilization of Diisopropylfluorophosphatase in Polyurethane Coatings | |
CA2142576A1 (en) | Antiperspirant Deodorant Compositions | |
EP1176160A3 (en) | Water soluble active sulfones of poly(ethylene glycol) | |
CA2026717A1 (en) | Absorbent for the removal of biomacromolecules such as ldl and endotoxins from whole blood in extracorporeal circuits | |
DE69315319D1 (en) | Bile acid bandage | |
AU5703298A (en) | Soluble polymer based matrix for chemically active water insoluble components | |
WO2004045542A3 (en) | Therapeutic bioconjugates | |
WO2001015738A3 (en) | Nitric oxide-producing hydrogel materials | |
AU3493900A (en) | One-part moisture-curable hydrocarbon polymer composition | |
EP0921139A4 (en) | Modified polymers containing poly(2-hydroxyethyl (meth)acrylate) segment in the molecule |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2444880 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002582992 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002728891 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2002728891 Country of ref document: EP |